$BKV

Tameron David sold $115K of BKV

Tameron David (Chief Financial Officer) sold 4,321 shares of BKV Corp (BKV) at $26.56 ($0.11M total) on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tameron David
Published Aug 21, 2026, 2:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 2:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BKV
Neutral
high confidence
Mentioned
$BKV
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BKVNeutralLow
01

Why it matters

The sale is modest and pre‑arranged, suggesting no new material information about BKV's prospects.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential tax planning or portfolio rebalancing; the 10b5‑1 plan indicates no insider information.

Relevance 3/10Novelty 2/10Timing: filed today

Background

Form 4 filings disclose insider trades; investors monitor them for signals of insider sentiment.

Company-level read

Ticker impact

$BKVNeutralHigh confidence
Context

Chief Financial Officer Tameron David sold 4,321 shares for $114,766 via a 10b5‑1 plan.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size (~$115k) is small relative to typical float and was pre‑arranged.

Market effects

None; the transaction is company‑specific and does not affect the broader sector.

None; BKV trades primarily on US exchanges with limited regional exposure.

None; the filing is a routine insider transaction.

Counterpoint

If the CFO is reducing exposure ahead of undisclosed negative news, the sell could foreshadow downside.

Key entities

  • BKV Corp

    Issuer of the Form 4 filing.

  • Tameron David

    Chief Financial Officer of BKV Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BKVHighAI 9/10

BKV Prices Upsized $500M 1.625% Convertible Notes Due 2031

BKV priced a $500M offering of 1.625% convertible senior notes due 2031, with an option for $75M more. The notes bear 1.625% interest, mature Oct 15, 2031, and have an initial conversion price of ~$31.93/share, a 32.5% premium to the $24.10 NYSE close on Sept 9, 2026. Estimated net proceeds are ~$481.8M, with ~$56.3M for capped calls and ~$35.0M for share repurchases.

$BKVMedAI 9/10

How Investors May Respond To BKV (BKV) Shelf Registration After Q2 Outperformance

BKV Corporation filed a $140.17M shelf registration for 5.32M shares after Q2 earnings beat expectations, with revenue and EPS exceeding estimates. The company's integrated natural gas and carbon capture model drove strong performance, but investors should consider potential dilution and high debt levels. BKV projects $1.6B revenue and $144.1M earnings by 2029, requiring 18.1% yearly revenue growth.

$BKVMedAI 8/10

BKV (BKV) Q2 2026 Earnings Call Transcript

BKV Corporation reported Q2 2026 adjusted EBITDAX of $142 million and adjusted net income of $51 million, and increased full-year upstream production guidance to a midpoint of 950 MMcf/d. Total cash costs fell 10% QoQ. Power generation rose, and net debt was $1.1 billion with liquidity of $840 million. BKV also raised 2026 strategic power capital guidance to $400-$475 million.